BMC Neuroscience

BMC Neuroscience is an open access, peer-reviewed journal from BioMed Central that has taken in every branch of neuroscience since volume one appeared in 2000, and its 2025 Journal Impact Factor is 3.3.《BMC 神经科学》是 BioMed Central 出版的开放获取同行评审期刊，自 2000 年第 1 卷起覆盖神经科学的各个分支，2025 年影响因子为 3.3。

Its stated remit runs from the molecular and cellular level through developmental, genetic and genomic work to systems and network explanations, with cognitive and behavioural studies of the nervous system in health and disease also in view.其范围从分子与细胞层面铺到发育与遗传研究，再延伸到系统与网络层面的机制解释，认知与行为研究同样在列，健康与疾病两种状态都受关注。

Research articles and reviews keep company with methodology papers, and database or software contributions can stand alone as publications in their own right.研究论文与综述之外还收方法学研究，数据库与软件也能单独成篇，一套新工具或一种记录技术因此不必附在别的研究之后。

Clarivate placed the title in the second quartile of neurosciences for 2025 at 156 of 330 journals, with a Journal Citation Indicator of 0.71, 64 articles that year and a cited half-life of 12.2 years.Clarivate 在 2025 年把它列在神经科学类目的第二四分位，330 种期刊中列第 156，期刊引文指标为 0.71，当年载文 64 篇，被引半衰期为 12.2 年。

Scope

• The journal's own description fixes the frame at every aspect of neuroscience, and the paragraphs that follow descend through the levels of organisation it names.刊物自己的说明把范围定在神经科学的各个方面，以下各条依照其中列出的组织层次展开。

• Molecular work sits at the base, where receptors and ion channels are common subjects, and intracellular signalling or the machinery of transmitter release appears just as often.分子层面的工作处在最基础的位置，受体与离子通道是常见对象，胞内信号与递质释放机制也在其中。

• Cellular studies come next, with neurons and glia at the centre, dendritic integration and synaptic plasticity taken as core material, and excitability treated as the cell's answer to its input.细胞层面的研究紧随其后，神经元与胶质细胞是主角，树突整合与突触可塑性属于核心，决定细胞如何回应输入的电兴奋性也在其中。

• Developmental questions are admitted in full, from neurogenesis and neuronal migration to axon guidance, synapse formation and the assembly of circuits.发育问题被完整接纳，从神经发生与神经元迁移，到轴突导向与突触形成，再到神经环路的组装。

• Genetics and genomics form a further strand, whether the subject is a model organism, a human variant or an expression programme that separates one cell type from another.遗传与基因组研究构成另一条线索，对象可以是模式生物，也可以是人类变异，还可以是不同细胞类型之间相异的表达程序。

• Systems and network physiology is treated as a subject in its own right, which lets sensory, motor and autonomic circuits, oscillations and long-range connectivity all find a place.系统与网络生理学被当作独立课题，感觉环路与运动环路各有位置，自主神经环路与节律活动同样如此，长程连接也在其中。

• Cognitive and behavioural research belongs here too, covering perception, attention, learning, memory, emotion, decision making and the behaviour of whole animals.认知与行为研究同属此列，知觉与注意是常见题目，学习与记忆是另一类，情绪与决策以及整体动物的行为都可以投稿。

• Health and disease hold equal standing, so work on injury, degeneration, epilepsy, pain, addiction or psychiatric illness is read on the same terms as work on normal function.健康与疾病地位相当，损伤与退变的研究，癫痫与疼痛的研究，成瘾与精神疾病的研究，与正常功能的研究按同一标准审读。

• Experimental studies are named explicitly in the description, and the range runs from a single recorded cell to behaving animals in a laboratory setting.实验研究在说明中被明确点名，范围从一个被记录的细胞，一直延伸到实验室里正在执行任务的动物。

• Methodological approaches to monitoring or manipulating nervous system function are welcomed, which covers imaging, electrophysiology, optogenetics and the design of behavioural assays.监测或操控神经系统功能的方法学受到欢迎，成像与电生理在其中，光遗传学与行为学范式设计同样如此。

• Computational modelling and the analysis of large recording sets have a place, since a model that reproduces the behaviour of a circuit counts as a result in itself.计算建模与大批记录数据的分析占有一席之地，能够复现某个环路行为的模型本身就构成结果。

• Database and software articles give community resources a route into the literature, and a well-documented dataset can be cited without a companion hypothesis paper.数据库论文与软件论文为社群资源提供了进入文献的通道，文档完备的数据集可以单独获得引用，不必附在一篇假设驱动的论文之后。

• Reviews are taken where a field has grown hard to survey, and the journal asks authors to weigh conflicting findings rather than list them.综述在某一领域已难以通览时被接收，刊物要求作者权衡彼此冲突的结果，不止于罗列。

History

• Volume one appeared in 2000, when BioMed Central of London opened a set of subject journals under its own imprint and neuroscience was among the first fields served.第 1 卷于 2000 年问世，同年设在伦敦的 BioMed Central 以自己的名义开办了一批学科期刊，神经科学是最早覆盖的领域之一。

• The title was electronic from the outset, with no print run to harmonise, and the single number 1471-2202 has served as both ISSN and eISSN since the first article.该刊从一开始就是电子刊，没有印刷版需要衔接，刊号 1471-2202 自首篇文章起同时充当 ISSN 与 eISSN。

• Its founding bargain was the one BioMed Central struck across the series, in which the author pays and the reader does not, and every paper is free on the day it appears.创刊时的交易条件与 BioMed Central 在整个系列中的做法一致，费用由作者承担，读者不付，每篇论文在刊出当天即可免费阅读。

• Springer Science+Business Media bought BioMed Central in 2008, and the London editorial office carried on under the same imprint while ownership changed above it.Springer Science+Business Media 于 2008 年收购 BioMed Central，伦敦的编辑部门在原刊名下继续运作，上层的所有权已经易主。

• The formation of Springer Nature in 2015 placed the title inside a larger publishing group, though readers saw no change in the address or in the article pages.2015 年 Springer Nature 组建，该刊随之进入一个更大的出版集团，读者看到的地址与文章页面却没有变化。

• Volume numbering has run without a break at one volume a year, so the 2026 volume is the twenty-seventh.卷次从未中断，每年一卷，2026 年的这一卷是第 27 卷。

• The volume is the unit of the sequence, a regular article is listed under issue 1 of its volume, and supplements carry their own numbering beside it.卷是序列的单位，常规文章列在该卷第 1 期之下，增刊另有自己的编号，与正刊并行。

• Indexing started early for a journal of this age, with MEDLINE and PubMed taking the title from volume one in 2000, Index Medicus alongside them and PubMed Central holding the full text.收录起步很早，MEDLINE 与 PubMed 自 2000 年第 1 卷即行收录，Index Medicus 同在其列，PubMed Central 存有全文。

• The impact factor stood at 3.264 in 2022, slipped to 2.4 in 2023 and 2.3 in 2024, then returned to 3.3 in 2025.影响因子 2022 年为 3.264，2023 年降至 2.4，2024 年降至 2.3，2025 年回到 3.3。

• Output has settled near 64 articles a year, while the citation stock has reached 5039.年载文量稳定在 64 篇上下，累计被引已达 5039 次。

• A cited half-life of 12.2 years is long for a journal born in 2000, which says that the back catalogue is still being read.12.2 年的被引半衰期对一本 2000 年创刊的期刊偏长，旧卷仍在被阅读与引用。

• In the 2025 assessment the title sat close to the median of its category, at the 52.9th percentile, and a Journal Citation Indicator of 0.71 tells the same story.2025 年评估中，该刊贴近类目中位，百分位为 52.9，期刊引文指标 0.71 讲的是同一件事。

• No change of name has ever been recorded, and the abbreviation BMC NEUROSCI has followed the title from the first volume to the present one.刊名从未更改，缩写 BMC NEUROSCI 从第 1 卷一直用到今天。

• It remains one of the subject journals of the BMC series, a family best known for BMC Biology and BMC Medicine.它至今仍是 BMC 系列中的一种学科期刊，这个系列里最知名的成员是《BMC Biology》与《BMC Medicine》。

Editors

• Manuscripts are handled by editors with subject training, and each paper goes to outside referees chosen for the question it asks rather than for seniority.稿件由受过学科训练的编辑处理，每篇论文送给外部评审人，人选取决于论文提出的问题，与资历无关。

• Review is single blind by default, so a referee sees the authors' names while the authors never learn who wrote the report.评审默认采用单盲，评审人看得到作者姓名，作者却不知道报告出自谁手。

• An open option runs alongside it, and where author and referee both agree the signed report is posted with the published article.与此并行的是开放选项，作者与评审人都同意时，署名的评审报告随文章一同公布。

• Authors may name potential referees at submission, and the handling editor is free to ignore the list when it looks too close to the work.作者可以在投稿时提名评审人，名单与工作关系过近时，责任编辑可以不采用。

• Decisions run from acceptance through minor and major revision to rejection, and a rejected paper may be appealed once with the grounds set out in writing.决定有接收与小修两种，也有大修与拒稿，被拒的稿件可以申诉一次，理由须写成文字。

• A proposal for a review can be sent to the editorial office before a full draft exists, which saves an author from writing a survey the journal will not take.综述的构想可以在成稿之前先送到编辑部，作者因此不必写出一篇刊物不会接收的综述。

• Research articles carry a structured abstract, reporting follows the guideline of the relevant community, and the ARRIVE checklist is expected for animal experiments.研究论文使用结构式摘要，报告遵循相应的学科规范，动物实验须按 ARRIVE 清单交代。

• A data availability statement is required with every submission, and sequence, image or code deposits are cited by accession, not described in passing.每次投稿都必须附数据可得性声明，序列与影像的存放处以登录号引用，代码同样如此，不作顺带一提。

• Authors keep copyright and the article is released under a Creative Commons Attribution licence, so reuse needs no permission from the publisher.作者保留版权，文章以知识共享署名许可发布，再次使用无须向出版方申请许可。

• The cost of publication falls on an article processing charge payable after acceptance, and waivers or discounts are granted to authors working in low income countries.出版成本由录用后支付的文章处理费承担，在低收入国家工作的作者可以申请减免。

• Every accepted paper is copy-edited and typeset before it receives a DOI, and the version of record is deposited in PubMed Central without an embargo.每篇录用的论文都经过文字编辑与排版后才获得 DOI，正式版本随即存入 PubMed Central，不设禁期。